Related News

Rockwell Medical Schedules 1st Quarter 2013 Investor Conference Call
5/3/2013 8:14:11 AM
Rockwell Medical to Present ESA-Sparing PRIME Study Data at 50th ERA-EDTA Congress, Istanbul 2013
5/6/2013 9:27:26 AM
Cytomedix to Host First Quarter 2013 Financial Results Conference Call on Friday, May 10, 2013
5/6/2013 9:38:59 AM
La Jolla Pharmaceutical Company Announces Completion of Phase 1 Portion of GCS-100 Clinical Trial in Chronic Kidney Disease
5/6/2013 10:17:08 AM
LIFESCI ADVISORS INITIATES COVERAGE OF LIPOCINE INC
5/7/2013 10:12:42 AM
Nanosphere Announces Record First Quarter Revenues and Strengthens Balance Sheet with $27 Million Debt and Equity Financing
5/8/2013 11:00:57 AM
Celsus Therapeutics Announces Positive Phase II Interim Results for MRX-6 in the Treatment of Contact Dermatitis
5/8/2013 11:20:30 AM
Cytomedix Reports First Quarter 2013 Financial Results
5/9/2013 4:28:41 PM
Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-Technologies Corporation
5/13/2013 4:20:21 PM
La Jolla Pharmaceutical Company Announces First-Quarter 2013 Financial Results and Highlights Recent Corporate Progress
5/13/2013 5:33:38 PM
La Jolla Pharmaceutical Company Presents Corporate Update at the MoneyShow
5/14/2013 8:14:43 PM
LifeSci Advisors Initiates Coverage of Prothena Corporation
5/15/2013 10:09:24 AM
Nanosphere to Present at UBS Global Healthcare Conference
5/15/2013 10:39:47 AM
New Validation and Clinical Outcome Data From Several Studies on Nanosphere's Gram-Positive and Gram-Negative Blood Culture Tests to Be Presented at ASM 2013
5/16/2013 10:18:40 AM
DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
5/16/2013 10:41:08 AM
Rockwell Medical Presents PRIME Study Results at the 50th ERA-EDTA Meeting in Istanbul, Turkey
5/20/2013 8:55:49 AM
Rockwell Medical Announces the Exercise of Over-Allotment Option
5/16/2013 4:42:22 PM
Cytomedix to Present at the World Stem Cells & Regenerative Medicine Congress 2013
5/17/2013 8:21:47 AM
Rockwell Medical Closes $40.3 Million Public Offering of Common Stock
5/20/2013 2:59:09 PM
BrainStorm Provides Update on Clinical Trial and Scientific Conference Activities
5/21/2013 10:20:51 AM
Showing 1 to 20 of 134 items. << previous   Page: 1 2 3 4 5 ...   next >>